Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05282654 · ClinicalTrials.gov registry record · NA
Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions
A NA study of Multiple Chronic Conditions and Adverse Event, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 1,300
- Enrollment target
- 2
- Study locations
NCT05282654: Recruiting NA study of Multiple Chronic Conditions and Adverse Event, sponsored by Brigham and Women's Hospital.
NCT05282654 is a NA study of Multiple Chronic Conditions and Adverse Event that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 1,300 participants, below the 4,743-participant average among 11 other Multiple Chronic Conditions trials with a reported enrollment target (73% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05282654, a NA study of Multiple Chronic Conditions and Adverse Event, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,300 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study aims to predict and minimize post-discharge adverse events (AEs) during care transitions through early identification and escalation of patient-reported symptoms to inpatient and ambulatory clinicians by way of predictive algorithms and clinically integrated digital health apps. We will (1) develop and prospectively validate a predictive model of post-discharge AEs for patients with multiple chronic conditions (MCC); (2) combine, adapt, extend, and iteratively refine our EHR-integrated digital health infrastructure in a series of design sessions with patient and clinician participants; (3) conduct a RCT to evaluate the impact of ePRO monitoring on post-discharge AEs for MCC patients discharged from the general medicine service across Brigham Health; and (4) use mixed methods to evaluate barriers and facilitators of implementation and use as we develop a plan for sustainability, scale, and dissemination.
Primary Outcome
The number of actual AEs during the 30-day post-discharge period
Conditions Studied
Interventions
- BEHAVIORAL ePRO Application
Study Locations (2)
Massachusetts
- Brigham and Women's Faulkner Hospital - Boston
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,300 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2026-10-15 |
| Phase | NA |
What NCT05282654 shows while recruiting
NCT05282654 is an interventional study that assigns participants to a tested intervention. Its 1,300 participants enrollment target places it among the larger protocols in the corpus, below the 4,743-participant average among 11 other Multiple Chronic Conditions trials with a reported enrollment target (73% lower).
The record links to 2 conditions, with Multiple Chronic Conditions appearing as the primary indexed condition, and to 1 intervention - of which ePRO Application is the first listed.
NCT05282654 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05282654 about?
NCT05282654 is a clinical study titled "Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions". This study aims to predict and minimize post-discharge adverse events (AEs) during care transitions through early identification and escalation of patient-reported symptoms to inpatient and ambulatory clinicians by way of predictive algorithms and clinically integrated digital health apps. We will (...
What is the current status of trial NCT05282654?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,300 participants. The study started on 2022-02-01. Estimated completion is 2026-10-15.
What conditions does trial NCT05282654 study?
This clinical trial studies the following conditions: Multiple Chronic Conditions, Adverse Event.
What interventions are being tested in trial NCT05282654?
The interventions under investigation include: ePRO Application (BEHAVIORAL).
Who is sponsoring clinical trial NCT05282654?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05282654 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Chronic Conditions
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05282654's enrollment target sits among peer trials
1,300 2nd of 11 the highest of 11 other Multiple Chronic Conditions trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Chronic Conditions trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Addressing Social Needs to Improve Health in Adults With Multiple Chronic Conditions
RECRUITING · NA
-
Optimizing Telehealth-delivery of a Weight Loss Intervention in Older Adults
RECRUITING · NA
-
Behavioral Activation + Occupational Therapy: An Innovative Intervention for Empowered Self-Management of Multiple Chronic Conditions
RECRUITING · NA
-
Church-based Intervention to Improve Physical Function
RECRUITING · NA
-
Precision Medicine and Physical Function
RECRUITING · NA
-
Collaboration Oriented Approach to Controlling High Blood Pressure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
- NCT04792684 · 1,300 participants
Collection of Samples USOPTIVAL Study
- NCT05166694 · 1,300 participants · NA
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
- NCT05705401 · 1,300 participants · Phase 3
Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI